GREENLAND MINES LTD Related Party Transaction, Amounts of Transaction
GREENLAND MINES LTD (GRML) reported Related Party Transaction, Amounts of Transaction of $20.00 thousand for the 9-month period ending 2024-09-30, per its 10-Q filed 2024-11-19.
Financial Statements › Notes
us-gaap:RelatedPartyTransactionAmountsOfTransaction · last filed 2024-11-19
- GREENLAND MINES LTD related party transaction, amounts of transaction for the quarter ending 2024-09-30 was -$11.00K, a 104.07% decline year-over-year.
- GREENLAND MINES LTD related party transaction, amounts of transaction for the quarter ending 2024-06-30 was -$1.51M.
- GREENLAND MINES LTD related party transaction, amounts of transaction for the quarter ending 2024-03-31 was $1.54M.
- GREENLAND MINES LTD related party transaction, amounts of transaction for the quarter ending 2023-12-31 was -$1.14M.
- GREENLAND MINES LTD related party transaction, amounts of transaction for fiscal 2022 was $0.00.
| Period end | Related Party Transaction, Amounts of Transaction 3 month | Related Party Transaction, Amounts of Transaction 6 month | Related Party Transaction, Amounts of Transaction 9 month | Related Party Transaction, Amounts of Transaction 12 month | Related Party Transaction, Amounts of Transaction 12 month as first filed |
|---|---|---|---|---|---|
| 2024-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-19 | -$1.52M derived: sum of 2 quarters · filed 2024-11-19 | $20.00K 10-Q · filed 2024-11-19 | -$1.12M derived: sum of 4 quarters · filed 2024-11-19 | |
| 2024-06-30 | -$1.51M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-19 | $31.00K 10-Q · filed 2024-08-19 | -$1.11M derived: sum of 3 quarters · filed 2024-11-19 | -$839.00K derived: sum of 4 quarters · filed 2024-11-19 | |
| 2024-03-31 | $1.54M 10-Q · filed 2024-05-23 | $400.00K derived: sum of 2 quarters · filed 2024-11-19 | $670.00K derived: sum of 3 quarters · filed 2024-11-19 | ||
| 2023-12-31 | -$1.14M derived: 10-Q 12 month − 10-Q 9 month · filed 2024-11-19 | -$870.00K derived: sum of 2 quarters · filed 2024-11-19 | $0.00 10-Q · filed 2024-11-19 | $1.54M 10-K · filed 2024-04-17 | |
| 2023-09-30 | $270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-17 | $1.14M 10-Q · filed 2023-11-17 | |||
| 2023-06-30 | $870.00K 10-Q · filed 2023-08-21 | ||||
| 2022-12-31 | $0.00 10-K · filed 2024-04-17 | ||||
| 2022-03-31 | $200.00K 10-Q · filed 2022-05-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| BIOCRYST PHARMACEUTICALS INC (BCRX) | United States | $2.175B | -6.63 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| NOVAVAX INC (NVAX) | United States | $1.748B | -6.26 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 |